The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TTCC-2022-01: Niraparib and dostarlimab in locally-advanced head and neck squamous cell carcinoma treated with (chemo) radiotherapy (RADIAN).
 
Marc Oliva
Honoraria - Bristol-Myers Squibb/Pfizer; Bristol-Myers Squibb/Pfizer; Merck; MSD Oncology; Transgene
Consulting or Advisory Role - Merck KGaA; MSD Oncology; MSD Oncology
Research Funding - ALX Oncology (Inst); Bayer (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); GlaxoSmithKline (Inst); ISA Pharmaceuticals (Inst); Merck; MSD Oncology (Inst); Roche (Inst); Seagen (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - BeiGene; Bristol-Myers Squibb/Pfizer; Merck; MSD Oncology
Other Relationship - Merck; MSD Oncology
 
Sandra Llop
Speakers' Bureau - MSD
Travel, Accommodations, Expenses - Merck; MSD
 
Zara Vidales
Honoraria - Pierre Fabre
Speakers' Bureau - Pierre Fabre
Travel, Accommodations, Expenses - GlaxoSmithKline; Merck; MSD; PharmaMar
 
Virginia Arrazubi
Consulting or Advisory Role - Bristol-Myers Squibb; MSD
Speakers' Bureau - BeiGene; Lilly
Travel, Accommodations, Expenses - Merck; MSD
 
Neus Baste
Consulting or Advisory Role - Amgen; Bayer; BioNTech; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Merck Serono; Merck Serono; MSD Oncology; Novartis; Roche; Roche
Research Funding - Merck Serono
 
Irene Brana
Consulting or Advisory Role - Achilles Therapeutics; Boehringer Ingelheim; Cancer Expert Now; eTheRNA Immunotherapies; Merck Sharp & Dohme; Merus; Sanofi
Speakers' Bureau - Bristol-Myers Squibb; Merck Serono; MSD; Roche
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Debiopharm Group (Inst); GlaxoSmithKline (Inst); Gliknik (Inst); Immutep (Inst); ISA Pharmaceuticals (Inst); Janssen Oncology (Inst); Kura Oncology (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Merus (Inst); Nanobiotix (Inst); Northern Biologics (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Roche (Inst); Seagen (Inst); Seagen (Inst); Shattuck Labs (Inst); Tolremo (Inst); VCN Biosciences (Inst)
Travel, Accommodations, Expenses - MSD Oncology
 
Beatriz Cirauqui
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; MSD
Speakers' Bureau - Bristol-Myers Squibb; Merck; MSD
Expert Testimony - Bristol-Myers Squibb; Merck; MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; MSD; Roche
 
Jon Cacicedo
No Relationships to Disclose
 
Jordi Giralt
No Relationships to Disclose
 
Jordi Marruecos
No Relationships to Disclose
 
María Plana Serrahima
Honoraria - BMS
Travel, Accommodations, Expenses - MSD Oncology
 
Rodolfo De Blas
No Relationships to Disclose
 
Valent?n Navarro
Employment - Institut Català d'Oncologia
 
Miguel Angel Pujana
No Relationships to Disclose
 
Laura Rodriguez Bel
No Relationships to Disclose
 
Vanessa Tierraseca
No Relationships to Disclose
 
Marisa Durán
No Relationships to Disclose
 
Carmen Montalbán
Employment - Pfizer (I)
Stock and Other Ownership Interests - Pfizer (I)
 
Alicia Lozano
No Relationships to Disclose
 
Ricard Mesia
Consulting or Advisory Role - Boehringer Ingelheim; GlaxoSmithKline; Merck KGaA; MSD; PDS Biotechnology; Roche; Seagan
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb; Merck KGaA; MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb